Age-related macular degeneration is a bilateral ocular condition in which the central area of the retina, known as the macula, is affected. Age-related macular degeneration is a progressive condition, and it is common among the geriatric population. The growing geriatric population is contributing to the rising incidence of age-related macular degeneration globally. As a result, there is a high demand for therapeutics to treat the condition. Pharmaceutical companies are leveraging this opportunity and are focusing on releasing drugs to treat age-related macular degeneration.
The global Ophthalmology for Age-related Macular Degeneration Diseases market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report aims to provide a comprehensive presentation of the global market for Ophthalmology for Age-related Macular Degeneration Diseases, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Ophthalmology for Age-related Macular Degeneration Diseases.
Report Scope
The Ophthalmology for Age-related Macular Degeneration Diseases market size, estimations, and forecasts are provided in terms of output/shipments (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Ophthalmology for Age-related Macular Degeneration Diseases market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Ophthalmology for Age-related Macular Degeneration Diseases manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
麻豆原创 Segmentation
By Company
DaVinci
Magnifying America
Freedom Scientific
LVI Low Vision International
NuEyes
Canadian Assistive Technologies
Merlin Ultra
HumanWare
Eschenbach Optik GmbH
Vispero
Esight
Rejoin Technology
Quantum
Segment by Type
Portable
Desktop
Segment by Application
Wet AMD
Dry AMD
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Mexico
Brazil
Turkey
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Ophthalmology for Age-related Macular Degeneration Diseases manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Ophthalmology for Age-related Macular Degeneration Diseases by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Ophthalmology for Age-related Macular Degeneration Diseases in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Ophthalmology for Age-related Macular Degeneration Diseases 麻豆原创 Overview
1.1 Product Definition
1.2 Ophthalmology for Age-related Macular Degeneration Diseases Segment by Type
1.2.1 Global Ophthalmology for Age-related Macular Degeneration Diseases 麻豆原创 Value Growth Rate Analysis by Type 2023 VS 2030
1.2.2 Portable
1.2.3 Desktop
1.3 Ophthalmology for Age-related Macular Degeneration Diseases Segment by Application
1.3.1 Global Ophthalmology for Age-related Macular Degeneration Diseases 麻豆原创 Value Growth Rate Analysis by Application: 2023 VS 2030
1.3.2 Wet AMD
1.3.3 Dry AMD
1.4 Global 麻豆原创 Growth Prospects
1.4.1 Global Ophthalmology for Age-related Macular Degeneration Diseases Production Value Estimates and Forecasts (2019-2030)
1.4.2 Global Ophthalmology for Age-related Macular Degeneration Diseases Production Capacity Estimates and Forecasts (2019-2030)
1.4.3 Global Ophthalmology for Age-related Macular Degeneration Diseases Production Estimates and Forecasts (2019-2030)
1.4.4 Global Ophthalmology for Age-related Macular Degeneration Diseases 麻豆原创 Average Price Estimates and Forecasts (2019-2030)
1.5 Assumptions and Limitations
2 麻豆原创 Competition by Manufacturers
2.1 Global Ophthalmology for Age-related Macular Degeneration Diseases Production 麻豆原创 Share by Manufacturers (2019-2024)
2.2 Global Ophthalmology for Age-related Macular Degeneration Diseases Production Value 麻豆原创 Share by Manufacturers (2019-2024)
2.3 Global Key Players of Ophthalmology for Age-related Macular Degeneration Diseases, Industry Ranking, 2022 VS 2023 VS 2024
2.4 Global Ophthalmology for Age-related Macular Degeneration Diseases 麻豆原创 Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.5 Global Ophthalmology for Age-related Macular Degeneration Diseases Average Price by Manufacturers (2019-2024)
2.6 Global Key Manufacturers of Ophthalmology for Age-related Macular Degeneration Diseases, Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of Ophthalmology for Age-related Macular Degeneration Diseases, Product Offered and Application
2.8 Global Key Manufacturers of Ophthalmology for Age-related Macular Degeneration Diseases, Date of Enter into This Industry
2.9 Ophthalmology for Age-related Macular Degeneration Diseases 麻豆原创 Competitive Situation and Trends
2.9.1 Ophthalmology for Age-related Macular Degeneration Diseases 麻豆原创 Concentration Rate
2.9.2 Global 5 and 10 Largest Ophthalmology for Age-related Macular Degeneration Diseases Players 麻豆原创 Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 Ophthalmology for Age-related Macular Degeneration Diseases Production by Region
3.1 Global Ophthalmology for Age-related Macular Degeneration Diseases Production Value Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
3.2 Global Ophthalmology for Age-related Macular Degeneration Diseases Production Value by Region (2019-2030)
3.2.1 Global Ophthalmology for Age-related Macular Degeneration Diseases Production Value 麻豆原创 Share by Region (2019-2024)
3.2.2 Global Forecasted Production Value of Ophthalmology for Age-related Macular Degeneration Diseases by Region (2025-2030)
3.3 Global Ophthalmology for Age-related Macular Degeneration Diseases Production Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
3.4 Global Ophthalmology for Age-related Macular Degeneration Diseases Production by Region (2019-2030)
3.4.1 Global Ophthalmology for Age-related Macular Degeneration Diseases Production 麻豆原创 Share by Region (2019-2024)
3.4.2 Global Forecasted Production of Ophthalmology for Age-related Macular Degeneration Diseases by Region (2025-2030)
3.5 Global Ophthalmology for Age-related Macular Degeneration Diseases 麻豆原创 Price Analysis by Region (2019-2024)
3.6 Global Ophthalmology for Age-related Macular Degeneration Diseases Production and Value, Year-over-Year Growth
3.6.1 North America Ophthalmology for Age-related Macular Degeneration Diseases Production Value Estimates and Forecasts (2019-2030)
3.6.2 Europe Ophthalmology for Age-related Macular Degeneration Diseases Production Value Estimates and Forecasts (2019-2030)
3.6.3 China Ophthalmology for Age-related Macular Degeneration Diseases Production Value Estimates and Forecasts (2019-2030)
3.6.4 Japan Ophthalmology for Age-related Macular Degeneration Diseases Production Value Estimates and Forecasts (2019-2030)
4 Ophthalmology for Age-related Macular Degeneration Diseases Consumption by Region
4.1 Global Ophthalmology for Age-related Macular Degeneration Diseases Consumption Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
4.2 Global Ophthalmology for Age-related Macular Degeneration Diseases Consumption by Region (2019-2030)
4.2.1 Global Ophthalmology for Age-related Macular Degeneration Diseases Consumption by Region (2019-2024)
4.2.2 Global Ophthalmology for Age-related Macular Degeneration Diseases Forecasted Consumption by Region (2025-2030)
4.3 North America
4.3.1 North America Ophthalmology for Age-related Macular Degeneration Diseases Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.3.2 North America Ophthalmology for Age-related Macular Degeneration Diseases Consumption by Country (2019-2030)
4.3.3 United States
4.3.4 Canada
4.4 Europe
4.4.1 Europe Ophthalmology for Age-related Macular Degeneration Diseases Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.4.2 Europe Ophthalmology for Age-related Macular Degeneration Diseases Consumption by Country (2019-2030)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Ophthalmology for Age-related Macular Degeneration Diseases Consumption Growth Rate by Region: 2019 VS 2023 VS 2030
4.5.2 Asia Pacific Ophthalmology for Age-related Macular Degeneration Diseases Consumption by Region (2019-2030)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Ophthalmology for Age-related Macular Degeneration Diseases Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.6.2 Latin America, Middle East & Africa Ophthalmology for Age-related Macular Degeneration Diseases Consumption by Country (2019-2030)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
5 Segment by Type
5.1 Global Ophthalmology for Age-related Macular Degeneration Diseases Production by Type (2019-2030)
5.1.1 Global Ophthalmology for Age-related Macular Degeneration Diseases Production by Type (2019-2024)
5.1.2 Global Ophthalmology for Age-related Macular Degeneration Diseases Production by Type (2025-2030)
5.1.3 Global Ophthalmology for Age-related Macular Degeneration Diseases Production 麻豆原创 Share by Type (2019-2030)
5.2 Global Ophthalmology for Age-related Macular Degeneration Diseases Production Value by Type (2019-2030)
5.2.1 Global Ophthalmology for Age-related Macular Degeneration Diseases Production Value by Type (2019-2024)
5.2.2 Global Ophthalmology for Age-related Macular Degeneration Diseases Production Value by Type (2025-2030)
5.2.3 Global Ophthalmology for Age-related Macular Degeneration Diseases Production Value 麻豆原创 Share by Type (2019-2030)
5.3 Global Ophthalmology for Age-related Macular Degeneration Diseases Price by Type (2019-2030)
6 Segment by Application
6.1 Global Ophthalmology for Age-related Macular Degeneration Diseases Production by Application (2019-2030)
6.1.1 Global Ophthalmology for Age-related Macular Degeneration Diseases Production by Application (2019-2024)
6.1.2 Global Ophthalmology for Age-related Macular Degeneration Diseases Production by Application (2025-2030)
6.1.3 Global Ophthalmology for Age-related Macular Degeneration Diseases Production 麻豆原创 Share by Application (2019-2030)
6.2 Global Ophthalmology for Age-related Macular Degeneration Diseases Production Value by Application (2019-2030)
6.2.1 Global Ophthalmology for Age-related Macular Degeneration Diseases Production Value by Application (2019-2024)
6.2.2 Global Ophthalmology for Age-related Macular Degeneration Diseases Production Value by Application (2025-2030)
6.2.3 Global Ophthalmology for Age-related Macular Degeneration Diseases Production Value 麻豆原创 Share by Application (2019-2030)
6.3 Global Ophthalmology for Age-related Macular Degeneration Diseases Price by Application (2019-2030)
7 Key Companies Profiled
7.1 DaVinci
7.1.1 DaVinci Ophthalmology for Age-related Macular Degeneration Diseases Corporation Information
7.1.2 DaVinci Ophthalmology for Age-related Macular Degeneration Diseases Product Portfolio
7.1.3 DaVinci Ophthalmology for Age-related Macular Degeneration Diseases Production, Value, Price and Gross Margin (2019-2024)
7.1.4 DaVinci Main Business and 麻豆原创s Served
7.1.5 DaVinci Recent Developments/Updates
7.2 Magnifying America
7.2.1 Magnifying America Ophthalmology for Age-related Macular Degeneration Diseases Corporation Information
7.2.2 Magnifying America Ophthalmology for Age-related Macular Degeneration Diseases Product Portfolio
7.2.3 Magnifying America Ophthalmology for Age-related Macular Degeneration Diseases Production, Value, Price and Gross Margin (2019-2024)
7.2.4 Magnifying America Main Business and 麻豆原创s Served
7.2.5 Magnifying America Recent Developments/Updates
7.3 Freedom Scientific
7.3.1 Freedom Scientific Ophthalmology for Age-related Macular Degeneration Diseases Corporation Information
7.3.2 Freedom Scientific Ophthalmology for Age-related Macular Degeneration Diseases Product Portfolio
7.3.3 Freedom Scientific Ophthalmology for Age-related Macular Degeneration Diseases Production, Value, Price and Gross Margin (2019-2024)
7.3.4 Freedom Scientific Main Business and 麻豆原创s Served
7.3.5 Freedom Scientific Recent Developments/Updates
7.4 LVI Low Vision International
7.4.1 LVI Low Vision International Ophthalmology for Age-related Macular Degeneration Diseases Corporation Information
7.4.2 LVI Low Vision International Ophthalmology for Age-related Macular Degeneration Diseases Product Portfolio
7.4.3 LVI Low Vision International Ophthalmology for Age-related Macular Degeneration Diseases Production, Value, Price and Gross Margin (2019-2024)
7.4.4 LVI Low Vision International Main Business and 麻豆原创s Served
7.4.5 LVI Low Vision International Recent Developments/Updates
7.5 NuEyes
7.5.1 NuEyes Ophthalmology for Age-related Macular Degeneration Diseases Corporation Information
7.5.2 NuEyes Ophthalmology for Age-related Macular Degeneration Diseases Product Portfolio
7.5.3 NuEyes Ophthalmology for Age-related Macular Degeneration Diseases Production, Value, Price and Gross Margin (2019-2024)
7.5.4 NuEyes Main Business and 麻豆原创s Served
7.5.5 NuEyes Recent Developments/Updates
7.6 Canadian Assistive Technologies
7.6.1 Canadian Assistive Technologies Ophthalmology for Age-related Macular Degeneration Diseases Corporation Information
7.6.2 Canadian Assistive Technologies Ophthalmology for Age-related Macular Degeneration Diseases Product Portfolio
7.6.3 Canadian Assistive Technologies Ophthalmology for Age-related Macular Degeneration Diseases Production, Value, Price and Gross Margin (2019-2024)
7.6.4 Canadian Assistive Technologies Main Business and 麻豆原创s Served
7.6.5 Canadian Assistive Technologies Recent Developments/Updates
7.7 Merlin Ultra
7.7.1 Merlin Ultra Ophthalmology for Age-related Macular Degeneration Diseases Corporation Information
7.7.2 Merlin Ultra Ophthalmology for Age-related Macular Degeneration Diseases Product Portfolio
7.7.3 Merlin Ultra Ophthalmology for Age-related Macular Degeneration Diseases Production, Value, Price and Gross Margin (2019-2024)
7.7.4 Merlin Ultra Main Business and 麻豆原创s Served
7.7.5 Merlin Ultra Recent Developments/Updates
7.8 HumanWare
7.8.1 HumanWare Ophthalmology for Age-related Macular Degeneration Diseases Corporation Information
7.8.2 HumanWare Ophthalmology for Age-related Macular Degeneration Diseases Product Portfolio
7.8.3 HumanWare Ophthalmology for Age-related Macular Degeneration Diseases Production, Value, Price and Gross Margin (2019-2024)
7.8.4 HumanWare Main Business and 麻豆原创s Served
7.7.5 HumanWare Recent Developments/Updates
7.9 Eschenbach Optik GmbH
7.9.1 Eschenbach Optik GmbH Ophthalmology for Age-related Macular Degeneration Diseases Corporation Information
7.9.2 Eschenbach Optik GmbH Ophthalmology for Age-related Macular Degeneration Diseases Product Portfolio
7.9.3 Eschenbach Optik GmbH Ophthalmology for Age-related Macular Degeneration Diseases Production, Value, Price and Gross Margin (2019-2024)
7.9.4 Eschenbach Optik GmbH Main Business and 麻豆原创s Served
7.9.5 Eschenbach Optik GmbH Recent Developments/Updates
7.10 Vispero
7.10.1 Vispero Ophthalmology for Age-related Macular Degeneration Diseases Corporation Information
7.10.2 Vispero Ophthalmology for Age-related Macular Degeneration Diseases Product Portfolio
7.10.3 Vispero Ophthalmology for Age-related Macular Degeneration Diseases Production, Value, Price and Gross Margin (2019-2024)
7.10.4 Vispero Main Business and 麻豆原创s Served
7.10.5 Vispero Recent Developments/Updates
7.11 Esight
7.11.1 Esight Ophthalmology for Age-related Macular Degeneration Diseases Corporation Information
7.11.2 Esight Ophthalmology for Age-related Macular Degeneration Diseases Product Portfolio
7.11.3 Esight Ophthalmology for Age-related Macular Degeneration Diseases Production, Value, Price and Gross Margin (2019-2024)
7.11.4 Esight Main Business and 麻豆原创s Served
7.11.5 Esight Recent Developments/Updates
7.12 Rejoin Technology
7.12.1 Rejoin Technology Ophthalmology for Age-related Macular Degeneration Diseases Corporation Information
7.12.2 Rejoin Technology Ophthalmology for Age-related Macular Degeneration Diseases Product Portfolio
7.12.3 Rejoin Technology Ophthalmology for Age-related Macular Degeneration Diseases Production, Value, Price and Gross Margin (2019-2024)
7.12.4 Rejoin Technology Main Business and 麻豆原创s Served
7.12.5 Rejoin Technology Recent Developments/Updates
7.13 Quantum
7.13.1 Quantum Ophthalmology for Age-related Macular Degeneration Diseases Corporation Information
7.13.2 Quantum Ophthalmology for Age-related Macular Degeneration Diseases Product Portfolio
7.13.3 Quantum Ophthalmology for Age-related Macular Degeneration Diseases Production, Value, Price and Gross Margin (2019-2024)
7.13.4 Quantum Main Business and 麻豆原创s Served
7.13.5 Quantum Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Ophthalmology for Age-related Macular Degeneration Diseases Industry Chain Analysis
8.2 Ophthalmology for Age-related Macular Degeneration Diseases Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Ophthalmology for Age-related Macular Degeneration Diseases Production Mode & Process
8.4 Ophthalmology for Age-related Macular Degeneration Diseases Sales and 麻豆原创ing
8.4.1 Ophthalmology for Age-related Macular Degeneration Diseases Sales Channels
8.4.2 Ophthalmology for Age-related Macular Degeneration Diseases Distributors
8.5 Ophthalmology for Age-related Macular Degeneration Diseases Customers
9 Ophthalmology for Age-related Macular Degeneration Diseases 麻豆原创 Dynamics
9.1 Ophthalmology for Age-related Macular Degeneration Diseases Industry Trends
9.2 Ophthalmology for Age-related Macular Degeneration Diseases 麻豆原创 Drivers
9.3 Ophthalmology for Age-related Macular Degeneration Diseases 麻豆原创 Challenges
9.4 Ophthalmology for Age-related Macular Degeneration Diseases 麻豆原创 Restraints
10 Research Finding and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 麻豆原创 Size Estimation
11.1.3 麻豆原创 Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer
DaVinci
Magnifying America
Freedom Scientific
LVI Low Vision International
NuEyes
Canadian Assistive Technologies
Merlin Ultra
HumanWare
Eschenbach Optik GmbH
Vispero
Esight
Rejoin Technology
Quantum
听
听
*If Applicable.